Loading clinical trials...

A Phase 2/3 Study in Adult and Adolescent Participants With SCD | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 2/3NCT05431088

A Phase 2/3 Study in Adult and Adolescent Participants With SCD

The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of osivelotor.

Lead sponsor: Pfizer•24 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Pfizer Pfizer CT.gov Call Center

CONTACT

1-800-718-1021 ClinicalTrials.gov_Inquiries@pfizer.com

Sponsors

Lead Sponsor

Pfizer

Related studies

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

NCT06477289 · Sickle Cell Disease

RECRUITINGPhase 3

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

NCT06612268 · Sickle Cell Disease

ATHNdataset Registry

NCT06820515 · Hemophilia, Thrombosis, and more

Functional Ovarian Reserve in Sickle Cell Disease

NCT07392216 · Sickle Cell Disease

RECRUITINGPhase 2

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

NCT05736419 · Sickle Cell Disease, Thalassemia, Beta, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 20, 2026Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2/PHASE3

Enrollment389

Start dateSep 2022

Last updatedMar 20, 2026

Condition

Sickle Cell Disease

Locations shown

Smilow Cancer Hospital

New Haven, Connecticut

Edward Jenner Research Group Center LLC

Plantation, Florida

Pediatric Hematology / Oncology a division of Kidz Medical services

West Palm Beach, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 20, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions